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Abstract. 
 
To investigate the role of 
 
b
 
-catenin in mam-
mary gland development and neoplasia, we expressed a
stabilized, transcriptionally active form of 
 
b
 
-catenin
 
lacking the NH
 
2
 
-terminal 89 amino acids (
 
D
 
N89
 
b
 
-cate-
nin) under the control of the mouse mammary tumor
virus long terminal repeat. Our results show that
 
D
 
N89
 
b
 
-catenin induces precocious lobuloalveolar de-
velopment and differentiation in the mammary glands
of both male and female mice. Virgin 
 
D
 
N89
 
b
 
-catenin
mammary glands resemble those found in wild-type
(wt) pregnant mice and inappropriately express cyclin
D1 mRNA. In contrast to wt mammary glands, which
resume a virgin appearance after cessation of lactation,
transgenic mammary glands involute to a midpregnant
status. All transgenic females develop multiple aggres-
sive adenocarcinomas early in life. Surprisingly, the
 
D
 
N89
 
b
 
-catenin phenotype differs from those elicited by
 
overexpression of 
 
Wnt 
 
genes in this gland. In particular,
 
D
 
N89
 
b
 
-catenin has no effect on ductal side branching.
This suggests that Wnt induction of ductal branching in-
volves additional downstream effectors or modulators.
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Introduction
 
b
 
-Catenin is a versatile multifunctional protein that is es-
sential for stable cell–cell adhesion and signal transduction
(McCrea et al., 1991; Butz et al., 1992; Gumbiner, 1995).
At the membrane, it facilitates cell–cell adhesion by con-
 
necting classical cadherins to the actin cytoskeleton via
 
a
 
-catenin (Cowin and Burke, 1996). Several Wnt signaling
 
cascades operate by inhibiting degradation of cytosolic
 
b
 
-catenin and promoting its nuclear entry (Nusse and Var-
mus, 1992; Gumbiner, 1995). Once in the nucleus, 
 
b
 
-cate-
nin forms a bipartite transcription factor with lymphoid
 
enhancer factor (Lef)
 
1
 
/T cell factor (Tcf) proteins (Beh-
rens et al., 1996; Molenaar et al., 1996), and modulates the
expression of an array of genes that encode proteins in-
volved in transcription, cell cycle regulation, apoptosis,
and matrix remodeling (see http://www.stanford.edu/
~rnusse/pathways/targets.html for a current list of target
genes and references). Perturbation of 
 
b
 
-catenin protein
levels produces dramatic effects in both embryonic and
adult tissues and has been found in many types of tumors
(Funayama et al., 1995; Haegel et al., 1995; Gat et al., 1998;
Harada et al., 1999; Polakis, 1999).
The mammary gland provides an attractive model in
which to study 
 
b
 
-catenin’s in vivo function, because the
majority of the patterning and proliferation that constitute
the development of this organ take place postnatally
(Daniel and Silberstein, 1987). Furthermore, mammary
differentiation during pregnancy, lactation, and involution
 
can be invoked cyclically.
 
 
 
Primary mammary epithelial
ducts are established before birth but remain quiescent
 
until puberty (
 
z
 
3 wk of age in the mouse), at which point
ovarian hormones cause secondary branches to grow from
club-shaped terminal end buds. The ducts extend, becom-
ing progressively branched, and fill the fat pad at 
 
z
 
12 wk
of age. The gland then remains dormant until the hor-
monal stimulus of pregnancy causes lobuloalveolar struc-
tures to develop. These structures increase dramatically in
size and number, synthesizing milk proteins during preg-
nancy and secreting them after birth. After weaning, the
alveolar epithelium undergoes apoptosis, causing the
mammary gland to involute and resume an appearance
similar to that of the pubertal ductal tree (Daniel and Sil-
berstein, 1987).
 
Mammary development and subsequent mammary cy-
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cles are synchronized to the reproductive state of the ani-
mal via hormonal induction but are, nevertheless, locally
patterned (Henninghausen and Robinson, 1998). There is
good reason to suspect that 
 
b
 
-catenin plays a seminal role
in this process, because it is central to the functions of
cadherins, Wnts, and Lef-1. Each of these proteins have
roles in mammary development and/or neoplasia. The
E-cadherin gene is frequently mutated in lobular breast
cancer, and P-cadherin null mice show precocious lobu-
loalveolar development (Berx et al., 1995; Radice et al.,
1997). The mammary gland shows differential expression
of several 
 
Wnt
 
 genes (Buhler et al., 1993; Gavin et al.,
1990; Weber-Hall et al., 1994), and 
 
Wnt-1
 
,
 
 -3
 
, and 
 
-10b
 
 in-
duce tumors when misexpressed in mammary epithelia
(Lane and Leder, 1997; Tsukamoto et al., 1988). Finally,
 
Lef-1
 
 null mice lack mammary glands, and thus derepres-
sion of genes regulated by Lef-1/
 
b
 
-catenin appears to be
essential for mammary gland development (van Gen-
deren et al., 1994).
To determine the effects of altering 
 
b
 
-catenin cytosolic
levels and transcriptional activity during postnatal mam-
mary gland development, we generated transgenic mice
expressing a constitutively active form of 
 
b
 
-catenin under
the control of the mouse mammary tumor virus long ter-
minal repeat. Our results show that 
 
D
 
N89
 
b
 
-catenin in-
duces precocious lobuloalveolar development and differ-
entiation in both male and female virgin mice. The
endpoint for involution differs in transgenics and normals,
and both virgin and breeding females develop multiple ag-
gressive adenocarcinomas early in life.
 
Materials and Methods
 
Plasmid Construction and Generation 
of Transgenic Mice
 
A cDNA encoding a myc-tagged, stabilized form of 
 
Xenopus
 
 
 
b
 
-catenin,
deleted in the first 89 amino acids, was generated by PCR using pCS2-
XBC provided to us by Dr. Barry Gumbiner (Memorial Sloan-Kettering,
New York, NY), as a template (McCrea et al., 1991). A 250-bp DNA frag-
ment was amplified using forward oligonucleotide 529Fx-myc (ctc ggatcc
gaattc gcc gcc
 
 ATG GAG CAA AAG CTT ATT TCT GAA GAG GAC
TTG
 
 AGA GCC CAG CGA GTT CGT GCT), which contains BamHI
and EcoRI restriction sites, Kozac’s sequence, a sequence encoding the
myc epitope (
 
MEQKLISEEDL
 
)
 
 
 
followed by amino acids 90–96 of 
 
Xeno-
pus
 
 
 
b
 
-catenin, and the reverse oligonucleotide 710R (GGG GAT
TGCTCGAGT GGC CAA TTC), encompassing an internal XhoI site at
base 448 of the coding region. The 727-bp BamHI
 
-
 
XhoI
 
 
 
fragment of
pCS2-XBC was replaced by the 237-bp BamHI
 
-
 
XhoI
 
 
 
PCR fragment to
generate pCS2-
 
D
 
N89BC. An EcoRI linker was introduced into the SnaBI
site in the 3
 
9
 
 end of the pCS2-
 
D
 
N89BC polylinker region, permitting the
2,160-bp insert to be excised as an EcoRI fragment, and subcloned into
the transgene cassette. The pMMTVEV transgene cassette, containing the
mouse mammary tumor virus long terminal repeat and rabbit 
 
b
 
-globin
(RBG) sequences which provide intron, splicing, and polyadenylation sig-
nals, was provided by Dr. Lynn Matrisian (Vanderbilt University, Nash-
ville, TN) (Witty et al., 1995). The 2,704-bp XhoI fragment containing
these sequences was excised, linkered with NotI restriction sites, and
cloned into pGEM5Z
 
1
 
 (Promega). This cassette permitted cloning of the
2,160-bp EcoRI fragment of pCS2-
 
D
 
N89BC into the EcoRI cloning site
embedded in the RBG sequence, and excision of the entire 4,864-bp trans-
gene MMTV-
 
D
 
N89
 
b
 
-catenin with NotI for injection. The PCR-generated
regions and newly generated cloning sites of all clones were fully se-
quenced. The NotI fragment carrying the transgene was purified by elec-
troelution, followed by dialysis and ethanol precipitation, and microin-
jected into the fertilized eggs of FVB/N mice (Taconic Farms) by the
Skirball Transgenic Facility. MMTV-Wnt-1 transgenic mice on an FVB/N
background were purchased from The Jackson Laboratory.
 
Southern Blot Analysis of Genomic DNAs
 
Genomic DNA was prepared as described (Charpentier et al., 2000). For
Southern blot analysis, 10–20 
 
m
 
g of genomic DNA samples was digested
with 80 U of EcoRI, separated by electrophoresis in a 1
 
3
 
 TAE-0.8% aga-
rose gel at 3 V/cm, and transferred to Nytran membranes (Schleicher &
Schuell). Blots were prehybridized for 1 h at 42
 
 
 
8
 
C in ULTRAhyb (Am-
bion, Inc.), then hybridized overnight at 42
 
 
 
8
 
C by addition of 50 ng of the
2,160-bp EcoRI fragment of MMTV-
 
D
 
N89
 
b
 
-catenin, radiolabeled by ran-
dom priming to a specific activity of 10
 
9
 
 cpm/
 
m
 
g (ICN Biomedicals). Blots
were washed twice for 5 min in 2
 
3
 
 SSC, 0.1% SDS and twice for 15 min in
0.1
 
3 
 
SSC, 0.1% SDS at 42
 
 
 
8
 
C, and exposed to PhosphorImager screens
(Molecular Dynamics). The approximate transgene copy number was de-
termined by adding 20 pg (2 copies), 200 pg (20 copies), and 2,000 pg (200
copies) of MMTV–
 
D
 
N89
 
b
 
-catenin to genomic DNA from a nontransgenic
mouse, and comparing relative intensities of hybridization. Differences in
DNA loading were calculated by cohybridization with a gene fragment (a
gift of Dr. Alex Joyner, New York University Medical School) specific for
the two copy gene 
 
engrailed 
 
(Wurst et al., 1994).
 
Northern Analysis
 
Mammary glands were homogenized in denaturing solution with a poly-
tron, and total RNA was prepared using the ToTally RNA kit (Ambion,
Inc.). 10–20 
 
m
 
g RNA was electrophoresed in 1% phosphate-glyoxal aga-
rose gels using the NorthernMax-Gly kit (Ambion, Inc.). The following
cDNA probes were gifts: casein and K18 (Caroline Alexander, University
of Wisconsin, Madison, WI), cyclin D1 (Richard Pestell, Albert Einstein
College of Medicine, Yeshiva University, New York, NY), and c-myc
(Anthony Brown, Strang Cancer Research Laboratory, The Rockefeller
University, New York, NY).
 
Immunoprecipitation and Western Blot Analysis
 
Mammary glands from F1 transgenic and wild-type (wt) sex-matched lit-
termates were cryosectioned, boiled in 200 
 
m
 
l of lysis buffer (25 mM Tris-
HCl, pH 7.4, 3 mM EDTA, 150 mM NaCl, 1% SDS, 10 
 
m
 
g/ml aprotinin, 1
mM PMSF), sonicated twice at stop 6, and pelleted for 15 min at 10,000 
 
g
 
.
Protein concentration of the supernatant was determined by the method
of Bradford, using a bicinchronic acid protein assay kit (Pierce Chemical
Co.). For immunoprecipitations, 
 
z
 
500 
 
m
 
g protein in 200 
 
m
 
l of lysis buffer
was processed for immunoprecipitation as described (Witcher et al.,
1996), then boiled in Laemmli sample buffer and subjected to 7.5% SDS-
PAGE. For Western blotting, 20-
 
m
 
g protein samples were boiled in 40 
 
m
 
l
of Laemmli sample buffer, then separated by electrophoresis through
7.5% SDS-PAGE, electrophoretically transferred to Protran membranes
(Schleicher & Schuell), and processed for Western blotting as described
(Charpentier et al., 2000).
 
Indirect Immunofluorescence
 
Mammary glands from F1 transgenic and normal sex-matched littermates
were removed, snap frozen in liquid nitrogen, and stored at 
 
2
 
70°C. 5-
 
m
 
m
frozen sections were attached to multiwell slides and processed for indi-
rect immunofluorescence as described (Charpentier et al., 2000). The fol-
lowing antibodies were used: mouse monoclonals 9E10 anti-myc epitope
(a gift of Dr. Harold Varmus, National Institutes of Health, Bethesda,
MD); anti–
 
b
 
-catenin and anti-smooth muscle actin (Sigma-Aldrich). Rab-
bit polyclonal antibodies used were specific for 
 
b
 
-catenin (Santa Cruz Bio-
technology, Inc.), cytokeratin 14 (BAbco), casein (a gift of Dr. Margaret
Neville, University of Colorado, Denver, CO), and ribophorin antibody (a
gift of Dr. Gert Kreibich, New York University Medical School).
 
Histology, TUNEL Analysis, and Whole Mounts
 
Mammary glands were fixed overnight or longer in 10% phosphate-buff-
ered formalin, embedded in paraffin, and sectioned. They were stained
with hematoxylin and eosin for histological analysis, or processed for ter-
minal deoxynucleotidyl transferase–mediated dUTP nick end labeling
(TUNEL) using the Promega Fluorescein Apoptosis Detection System
(Promega). For whole mount tissue preparations, mammary glands
were processed as described (http://mammary.nih.gov/tools/histological/
Histology/index.html#a1). 
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Results
 
MMTV-
 
D
 
N89
 
b
 
-Catenin Is Expressed in Luminal 
Epithelial Cells of the Mammary Gland
 
We generated a form of 
 
b
 
-catenin deleted in the NH
 
2
 
-ter-
minal 89 amino acids (
 
D
 
N89
 
b
 
-catenin) that retains cad-
herin/catenin binding, and has greater stability in the cyto-
plasmic pool (Munemitsu et al., 1996). 
 
D
 
N89
 
b
 
-catenin was
placed under the control of the mouse mammary tumor vi-
rus long terminal repeat (Fig. 1 A), which directs transgene
expression to mammary and salivary glands in the very
early stages of puberty, and is hormonally upregulated by
progesterone during estrus and pregnancy (Witty et al.,
1995). 12 mice showed integration of the transgene. F1
Figure 1.  (A) Structure of the
transgene construct. DNA se-
quence encoding a myc epitope
tag (black box), followed by se-
quence encoding the truncated
DN89-terminal domain, 13 cen-
tral Armadillo (Arm) repeats,
and the COOH-terminal do-
main of Xenopus  b-catenin
(shaded boxes) was embedded
in  b-globin intron/exon/polyade-
nylation sequences (bG), and
cloned downstream of the
mouse mammary tumor virus
long terminal repeat (MMTV
LTR). Pertinent restriction sites
are indicated: N, NotI; B,
BamHI; E, EcoRI. (B) 9E10 an-
tibody, which specifically recog-
nizes the human myc epitope tag
and does not cross-react with
murine c-myc, was used to
immunoprecipitate myc-tagged
DN89b-catenin from extracts of
the mammary glands from 12 in-
dividual transgenic lines. This
product was detected in three
lines (lines 1, 3, and 5) by West-
ern blotting with the same anti-
body. Note the lower band,
which migrates at Mr z 50,000,
is the IgG band from the 9E10
immunoprecipitation detected
by the HRP-rabbit anti–mouse.
(C) Southern blot detection of
the DN89b-catenin transgene in
the tail genomic DNA of trans-
genic (T) and normal (N) litter-
mates of F1 from lines 1, 3, and
5, as indicated. Membranes
were hybridized with the 32P-
labeled  DN89b-catenin cDNA insert (DbC), and the mouse engrailed gene (en) fragments, which detect fragments of 2,160 bp and 5 kb,
respectively, as indicated. Lanes marked 200, 20, and 2 show respective copy equivalents of DN89b-catenin cDNA plasmid. (D) Rela-
tive expression levels of DN89b-catenin protein in lines 5 and 3 as detected by Western blotting of equal amounts of total mammary
proteins with anti-myc antibody. Labels on the left indicate exposure time to film after incubation in ECL reagent. Arrows point to the
75-kD DN89b-catenin product; asterisks indicate nonspecific band detected by the anti–mouse IgG antibody. Detection of ribophorin
was used as a loading control. (E) Western blot showing expression of DN89b-catenin (top) in line 5 transgenic mice during mammary
development and differentiation. No reaction was seen on an identical blot of wt littermates (data not shown). Immunodetection of ker-
atin 14 on the same blot (bottom) is shown to control for epithelial content of the sample. Preg, pregnancy; inv, involution. (F) Western
blot of equal amounts of total proteins from day 16 pregnant mammary glands from line 5 mice showing expression of endogenous
E-cadherin (top) and the DN89b-catenin transgenic product and endogenous b-catenin detected with the same anti–b-catenin antibody
(bottom). Note densitometry of three similar blots showed that the transgene is expressed to approximately threefold the level of en-
dogenous b-catenin found in wt mice. The transgene downregulates endogenous b-catenin by one third, and upregulates E-cadherin
twofold compared with wt levels. (G–J) Indirect immunofluorescence on frozen sections of mammary gland from 6-mo-old virgin line 5
mice (G and J) or day 16 pregnant line 3 mice (H–I). DN89b-catenin is detected in green (G and H) using 9E10 anti-myc antibody. En-
dogenous b-catenin detected with rabbit anti–b-catenin shown in red (I). Double immunolabeling to detect DN89b-catenin in red and
smooth muscle actin, which demarcates the position of myoepithelial cells in green (J). Note the transgene is located at the intercellular
borders of the luminal epithelial cells.The Journal of Cell Biology, Volume 153, 2001 558
mice from founders 1, 3, and 5 expressed the transgene
protein product DN89b-catenin, as detected by Western
blotting of immunoprecipitations of mammary extracts
with 9E10 antibody that specifically recognizes the NH2-
terminal human c-myc epitope tag present on the trans-
gene product, and does not react with endogenous mouse
c-myc (Fig. 1 B). These lines of mice contained z50, 1, and
45 copies of the transgene (Fig. 1 C), and varied greatly in
their levels of DN89b-catenin expression (Fig. 1 D), thus
permitting dose responsiveness of the phenotype to be as-
sessed. Expression of DN89b-catenin was detectable in
7-wk virgin mammary glands, maximal during pregnancy,
and remained elevated after 10 d of involution (Fig. 1 E).
DN89b-catenin caused proportional downregulation of en-
dogenous b-catenin, and upregulation of endogenous
E-cadherin. These effects were most obvious in the high
expressing line 5 (Fig. 1 F). Immunofluorescent staining of
frozen sections of mammary gland with an anti-myc anti-
body specifically detected DN89b-catenin along the inter-
cellular borders of the epithelium of the mammary ducts,
and detected alveoli in both the high expressing lines (Fig.
1 G) and the low expressing line 3 (Fig. 1, H and I). No
such staining was found in tissue sections from wt litter-
mates (data not shown). Double immunofluorescence us-
ing anti-myc antibody to detect DN89b-catenin, and anti-
smooth muscle actin to define the myoepithelial cells,
confirmed that DN89b-catenin expression was restricted to
the luminal epithelium (Fig. 1 J). As reported previously
for other tissues, DN89b-catenin was not detected in the
nucleus (Gat et al., 1998; Wong et al., 1998). Nevertheless,
the upregulation of putative target genes (see below) sug-
gests that sufficient DN89b-catenin is in the nucleus for it
to be transcriptionally active in this tissue.
DN89b-Catenin Induces Precocious Lobular 
Development of Virgin Mammary Gland
To determine the effect of MMTV–DN89b-catenin on
early mammary development, we examined whole mount
preparations of mammary glands from female, virgin
transgenic and nontransgenic (wt) littermates that were
matched for stage of the estrous cycle (Fig. 2). Even at
early stages of puberty, marked differences could be seen
in both of the high expressing lines between transgenic
and wt mice (Fig. 2). At 4 wk, wt mammary epithelial
ducts had commenced proliferation from the terminal end
buds, and extended to the lymph node (Fig. 2 A). At
higher magnification they displayed a smooth surface (Fig.
2 B). In transgenic littermates, the ducts were shorter,
wider (Fig. 2 D), and covered with small lobular protuber-
ances (Fig. 2 E). Extensive arrays of lobules were evident
even at low magnification in 8-wk-old transgenic mice
(Fig. 2, C and F).
At the end of puberty (12 wk), wt ducts were smooth
and had small, regularly spaced side branches (Fig. 3, A
and B). However, virgin DN89b-catenin transgenic mam-
mary glands showed extensive lobuloalveolar develop-
ment of the type that is normally associated with the hor-
monal stimulation of pregnancy (Fig. 3, C and D). The
MMTV–DN89b-catenin phenotype contrasts strikingly to
the feathery, hyperbranched appearance of mammary
glands from MMTV-Wnt-1 mice of the same age and ge-
netic background (Fig. 3, E and F). Virgin MMTV-Wnt-1
Figure 2. Morphology  of
DN89b-catenin mammary
glands shows precocious lob-
ular development during
early puberty. Whole mounts
of inguinal mammary glands
stained with carmine alum
from wt (A–C) and trans-
genic (D–F) 4-wk (A, B, D,
and E) and 8-wk (C and F)
line 5 littermates matched for
stage of the estrous cycle.
LN, lymph node. Note the
extensive lobuloalveolar de-
velopment on the transgenic
glands (arrows in E). Images
in B and E show higher mag-
nifications of the areas
bracketed in A and D. Insets
in C and F are higher magni-
fications of bracketed areas.Imbert et al. b-Catenin in Mammary Gland 559
mammary glands (Fig. 3 F) resembled those of wt mice in
the early stage of pregnancy (8 d postcoitum [dpc]) (Fig. 3
G). In contrast, mammary glands from virgin DN89b-cate-
nin mice (Fig. 3 D) resembled those of mid- to late preg-
nant (13 dpc) wt mice (Fig. 3 H). Mammary glands from
pregnant DN89b-catenin mice (Fig. 3, I and J) consistently
showed lobular hyperplasia compared with those of wt lit-
termates at the same stage of pregnancy (Fig. 3, G and H).
Differences between wt and transgenic animals from the
low expressing line 3 were subtle during early develop-
ment (data not shown), but became obvious with age (Fig.
4, A–D). Older DN89b-catenin line 3 mice again showed
lobuloalveolar development in virgins with no indication
of hyperbranching (Fig. 4, A and B). Thus, the temporal
appearance of the DN89b-catenin phenotype correlates
with the dose of the transgene. Its later appearance in the
low expressing line is likely due to the additive effects of
repeated bursts of estrus on expression of the MMTV long
terminal repeat.
DN89b-Catenin Induces Lobuloalveolar Development 
along the Primary Branch of the Male Rudiment in the 
Absence of Hormonal Stimuli
As DN89b-catenin female mice show lobular development
in the absence of the hormonal stimulation associated with
pregnancy, we asked if this phenotype could also be in-
duced in males, in the complete absence of ovarian hor-
monal function. Mammary glands develop as epidermal
invaginations during embryogenesis in a process that is
similar in both males and females up to day 14. At this
point they are pinched off in males by androgen-induced
mesenchymal constriction (Sakakura, 1987). In four pairs
of whole mounts, the mammary rudiment of wt FVB/N
mice formed a small blind duct at one end of the fat pad,
Figure 3.  Comparison of the
morphology of mature wt,
MMTV-DN89b-catenin, and
MMTV-Wnt-1 transgenic vir-
gin and pregnant mammary
glands. Whole mounts of
inguinal mammary glands
stained with carmine alum
from 12-wk virgin wt (A and
B) and DN89b-catenin trans-
genic littermates (C and D),
and a 12-wk Wnt-1 transgenic
mouse (E and F). Mammary
glands from 8- and 13-d-old
pregnant wt (G and H) and
DN89b-catenin (I and J) lit-
termates. Note that DN89b-
catenin virgin mice show
a hyperlobular phenotype,
whereas Wnt-1 virgin mice
show a feathery hyper-
branched phenotype.The Journal of Cell Biology, Volume 153, 2001 560
occupying ,2% of the gland (Fig. 4 E). In their DN89b-
catenin littermates from the high expressing lines, this duct
was covered in lobuloalveolar structures (Fig. 4 E). Signif-
icantly, the ducts did not branch or elongate, as reported
for MMTV-Wnt-1 mice, nor did they expaand into the
male fat pad, as occurs in MMTV-Wnt-10b mice (Tsuka-
moto et al., 1988; Lane and Leder, 1997). No phenotype
was observed in males of the low expressing line 3. Thus,
DN89b-catenin specifically induces lobuloalveolar forma-
tion rather than hyperbranching in a dose-dependent man-
ner in males, and can do so in the absence of female hor-
monal stimuli.
DN89b-Catenin Induces Functional Differentiation 
of Mature Virgin Mammary Gland
Histological examination of sections of the mammary
glands of 6–8-mo-old virgin female wt and transgenic mice
from low expressing line 3 (Fig. 4 D) and high expressing
line 5 (Fig. 5, A–D) confirmed that DN89b-catenin induces
extensive alveolar development. Large intracellular vesi-
cles could be seen in the cuboidal cells lining the alveolar
lumina of transgenic glands (Fig. 5 D), demonstrating that
DN89b-catenin induces a secretory phenotype in the epi-
thelium. To investigate if the precocious alveolar develop-
ment was accompanied by functional differentiation, we
examined expression levels of the milk protein b-casein in
virgin and pregnant transgenic and wt littermates. As ex-
pected, b-casein expression was not detectable in wt virgin
mice; its expression began around day 8 of pregnancy, be-
came robust around day 13 of pregnancy, and was down-
regulated significantly by day 10 of involution (Fig. 5, E
and F). In contrast, young virgin transgenic mice produced
low but detectable levels of b-casein, and old virgins pro-
duced amounts surpassing those seen during midpreg-
nancy in wt mice (Fig. 5, E and F). Taken together, these
data show that DN89b-catenin induces lobular develop-
ment and functional differentiation of the virgin mammary
gland to that of midpregnant status.
Figure 4. Lobuloalveolar
development in older virgin
females of the low expressing
line and in male mice. Whole
mounts of inguinal mammary
glands stained with carmine
alum (A–C) and hematoxylin
and eosin–stained sections of
mammary gland (D) from 20-
wk-old (A) and 40-wk-old (B
and C) wt and DN89b-cate-
nin transgenic littermates
from the low expressing line
3. Note that low expressing
line 3 DN89b-catenin virgin
mice also show aberrant hy-
perlobular development with
no evidence of ductal hyper-
branching. (E) 1-yr-old wt
and  DN89b-catenin trans-
genic male littermates from
line 5.Imbert et al. b-Catenin in Mammary Gland 561
DN89b-Catenin Upregulates Cyclin D1 and c-myc 
mRNA in Virgin Mammary Gland
The phenotypes of cyclin D12/2 mice support a role for cy-
clin D1 expression in the epithelial cell autonomous induc-
tion of lobuloalveolar structures (Sicinski et al., 1995;
Fantl et al., 1999). Cyclin D1 and c-myc induce precocious
mammary development and transformation when overex-
pressed, and genes are targets of b-catenin transcriptional
activity (Sinn et al., 1987; Wang et al., 1994; He et al., 1998;
Tetsu and McCormick, 1999). Therefore, we examined the
effect of MMTV–DN89b-catenin on cyclin D1 and c-myc
mRNA levels during mammary development. As ex-
pected, wt mice do not express significant levels of cyclin
D1 mRNA, until midpregnancy (Fig. 6) (Stepanova et al.,
Figure 5.  Histological and biochemical evaluation shows evidence of precocious epithelial differentiation in DN89b-catenin virgin
mice. (A–D) Hematoxylin and eosin–stained sections of mammary gland from 6-mo-old virgin wt (A and B) and DN89b-catenin (C and
D) littermates. Note the presence of vesicles in the transgenic samples. (E) Western blot of total proteins from the inguinal mammary
glands at various stages of development, pregnancy (preg), and involution (inv) with anti–b-casein antibody and anti-keratin 14 anti-
body on the same blot, which serves as a control of epithelial content of the sample. (F) Graph of densitometry figures derived from the
casein blots shown in E after normalization for keratin 14 levels. Note b-casein is expressed in DN89b-catenin but not wt virgin mice,
and in all pregnant mice.The Journal of Cell Biology, Volume 153, 2001 562
1996, 2000). In contrast, virgin DN89b-catenin mice ex-
press abnormally high levels of cyclin D1 mRNA as well as
elevated levels of c-myc mRNA (Fig. 6). Expression levels
of these mRNAs were similar in wt and transgenic glands
throughout pregnancy.
DN89b-Catenin Effects on Involution 
of the Mammary Gland
We next asked whether MMTV–DN89b-catenin mam-
mary glands were able to involute correctly after cessation
of lactation. Transgenic and wt littermates were allowed to
give birth and nurse seven pups for 7 d. We killed the
mothers at various time points up to 21 d later, and pro-
cessed their mammary glands as whole mounts and histo-
logical sections. Involution is a two-step process. Early af-
ter the removal of pups, programmed cell death of the
secretory epithelium occurs with loss of differentiated
product (Lund et al., 1996). Epithelial cell death continues
during the second stage, at which time proteinases re-
model the stroma and a biosynthetic wave of adipogenesis
restores the fat pad (Lund et al., 1996). No significant his-
tological difference was seen between the wt (Fig. 7 A,
top) and transgenic samples (Fig. 7 A, bottom), up to day
7 of involution. Both wt and transgenic glands undergo an
early apoptotic process that rapidly peaks in a scheduled
fashion in both samples at day 3 of involution, as assessed
by TUNEL staining of tissue sections (Fig. 7 B and Fig. 8
A). By day 10, however, wt mammary glands show greater
alveolar degeneration and overall reduction in the relative
epithelial mass than the transgenic alveolar epithelium,
which remains hyperplastic (Fig. 8 B). This discrepancy
between the wt and transgenic glands persists even up to
day 21, the time at which involution is considered com-
plete in wt mice. The transgenic epithelial cells contain
many large intracellular vesicles, indicating continued
secretory activity (data not shown). Moreover, casein and
cyclin D1 mRNA expression, which are lost in wt mice,
continue to be detected at day 21 in transgenic mice (Fig. 8
C). Thus, the mammary gland reverts to the virgin status
in both wt and transgenic animals. However, as virgin
DN89b-catenin mice already have a midpregnancy pheno-
type (Fig. 5, E and F), their involution does not result in
full loss of alveolar structure or differentiation.
DN89b-Catenin Induces Adenocarcinomas in 
100% of Female Mice
In both transgenic lines, breeding females were unable to
feed the third and subsequent litters of pups, and devel-
oped large mammary growths (Fig. 9 A). This did not oc-
cur in wt littermates. The mammary growths began as
large, fluid-filled cysts, and at later times formed highly
vascularized encapsulated tumors with necrotic centers
(Fig. 9 B). Metastases were not observed, but the tumors
sometimes showed invasion of local muscular tissues. The
tumors displayed both a glandular (Fig. 9, C and D) and an
undifferentiated pattern (Fig. 9, C and F) consisting of
tightly packed epithelial cells (Fig. 9 F). A secretory phe-
notype was variably evident in both components (Fig. 9
E). Cellular atypia and mitotic activity were most promi-
nent in the undifferentiated regions (Fig. 9 F). These fea-
tures are consistent with adenocarcinoma with glandular,
secretory, and undifferentiated elements. Northern analy-
sis of tumors that developed in virgin animals revealed
that both cyclin D1 and c-myc mRNA levels were elevated
in tumor samples, compared with mammary tissue from wt
littermates after normalization to K18 levels to correct for
the expansion of the epithelial compartment seen in the
tumor samples (Fig. 9 G). To quantify the tumor incidence
and rate of progression, we established wt and transgenic
pairs of males, virgin females, and breeding females from
both high and low expressing lines 5 and 3, respectively
(Fig. 9 H). 100% of transgenic breeding females devel-
oped multiple (average three per mouse) large tumors,
which became visible at z4 mo of age in the high express-
ing line 5, and at 6.5 mo of age in the low expressing line 3.
In both lines the tumors grew rapidly, requiring killing of
the animals z4 wk later. Tumors developed later in life
(z7 mo) in virgin females of the high expressing line 5,
and grew with similar frequency and rate of progression.
30% of virgin females of the low expressing line 3, which
are currently 13 mo old, have developed mammary tu-
mors. Only one male (line 5) developed a tumor.
Discussion
Our goal in this study was to determine the effect of in-
creasing the pool of transcriptionally active b-catenin on
mammary gland development and pathology. Our first ob-
servation was that expression of MMTV–DN89b-catenin
during early mammary development produced a mild re-
tardation in ductal extension. This effect is reminiscent of
the inhibition of tubulogenesis in MDCK cysts produced
by a similar mutant, DN90b-catenin, which was hypothe-
sized to interfere with the ability of adenomatous polypo-
sis coli to bundle microtubules at the tips of cell extension
(Nathke et al., 1996; Pollack et al., 1997). However, the
most striking change elicited by the early expression of
MMTV–DN89b-catenin is the inappropriate lobuloalveo-
lar development of the virgin mammary gland. Stem cells
that generate the alveoli are dispersed throughout the
mammary gland and cyclically activated during pregnancy
(Kordon and Smith, 1998). DN89b-catenin’s specific effect
Figure 6.  Northern analysis of cyclin D1 and c-myc mRNA lev-
els in wt and DN89b-catenin mammary glands. mRNA was ex-
tracted from virgin (10 wk [10w Vir]), midpregnant (8 d [8d
Preg]), and late pregnant (18 d [18d Preg]) mammary glands.
Northern blots were prepared and probed with cDNAs encoding
cyclin D1, c-myc, and K18 as a control to permit normalization
for epithelial content of the mRNA samples. Note cyclin D1 and
c-myc levels are abnormally elevated in transgenic (TG) virgin
mice compared with their wt littermates.Imbert et al. b-Catenin in Mammary Gland 563
on these mammary stem cells parallels its actions in mouse
skin and intestine. DN89b-catenin reprograms both epi-
dermal and follicle stem cells to generate supernumerary
hair follicles and induces stem cells in the intestinal crypts
to form adenomatous polyps, but has no effect on the dif-
ferentiated cells of the villi (Gat et al., 1998; Wong et al.,
1998; Harada et al., 1999). As mice lacking Lef-1 or Tcf-4,
the transcriptional partners of b-catenin, fail to form mam-
mary glands and intestinal crypt cells, respectively, it has
been proposed that b-catenin’s ability to modify Lef/Tcf
function may maintain stem-like multipotency (van Gen-
deren et al., 1994; Korinek et al., 1998).
b-Catenin and Wnt Signaling in Mammary Gland
DN89b-catenin induces lobuloalveolar development in
males as well as females, and therefore, joins several pro-
teins whose overexpression or loss of function bypasses
the requirement for hormonal stimuli to induce lobuloal-
veolar development (Henninghausen and Robinson, 1998;
Robinson et al., 2000). Among this list of proteins, there is
a considerable body of data to link b-catenin, Wnts, cad-
herins, matrix metalloproteinases, and cyclin D1 into a pu-
tative pathway. Wnts comprise a large family of secreted,
short-range signaling proteins. Mammary gland expresses
Wnt-2, -5a, -7b, and -10b during puberty, expresses Wnt-4,
Figure 7.  A comparison of
early involution of wt and
DN89b-catenin mammary
glands. (A) Hematoxylin and
eosin–stained sections of wt
(top) and DN89b-catenin
(bottom) inguinal mammary
glands from littermates 1, 3,
5, and 7 d of involution (i) af-
ter removal of pups, as indi-
cated. (B) Apoptotic changes
detected by TUNEL staining
of sections from wt (top) and
DN89b-catenin (TG, bottom)
inguinal mammary glands 1
and 3 d after removing pups,
as indicated (1i, 3i). Note no
significant differences were
observed between wt and
transgenic samples during
this early stage of involution.The Journal of Cell Biology, Volume 153, 2001 564
-5b, and -6 during pregnancy, loses Wnt expression during
lactation, and resumes it again during involution (Gavin et
al., 1990; Buhler et al., 1993; Weber-Hall et al., 1994). The
phenotype induced by MMTV–DN89b-catenin most
closely resembles the changes associated with late preg-
nancy, suggesting that endogenous b-catenin may nor-
mally convey signals from the pregnancy-associated Wnts.
Wnt-4 has recently been demonstrated to be regulated by
progesterone (Brisken et al., 2000). To date, there is no ev-
idence to connect Wnt-4, -5b, or -6 to b-catenin. Indeed,
these particular Wnts do not upregulate b-catenin in
C57MG cells, although it is not clear if these cells express
appropriate receptors (Shimizu et al., 1997). In contrast,
Wnt-2, which is expressed in stromal cells during ductal
proliferation and is maintained during pregnancy, does up-
regulate b-catenin in C57MG cells, and is, therefore, a po-
tential paracrine regulator of b-catenin function in vivo
(Shimizu et al., 1997). Significantly, Wnt-2 amplification
has been found in mouse mammary tumors, and its upreg-
ulation has been reported in human breast carcinomas
(Roelink et al., 1992; Dale et al., 1996).
Wnt-10b, a gene that is expressed in mammary gland,
and Wnt-1 and Wnt-3, which are normally silent in this tis-
sue, share with DN89b-catenin the ability to induce lobular
hyperplasia and adenocarcinomas when expressed from
the MMTV promoter (Tsukamoto et al., 1988; Roelink
et al., 1990; Lane and Leder, 1997). This strongly sug-
gests that b-catenin mediates the proliferative and onco-
genic actions of these Wnts. However, the early morpho-
genic phenotypes of MMTV-Wnt-1, Wnt-3, Wnt-10b, and
DN89b-catenin mice do not fully superimpose (Tsuka-
moto et al., 1988; Lane and Leder, 1997). DN89b-catenin
specifically induces lobuloalveolar development in fe-
males and males, whereas Wnt-1 and Wnt-10b additionally
induce feathery, ductal hyperbranching in females and sig-
nificant male ductal extension. There are several possible
explanations for the partial incongruence among the phe-
notypes. First, it can be argued that different Wnts may
sustain distinct levels of b-catenin that critically determine
the phenotype. This argument can be dismissed, as both
high and low expressing lines of DN89b-catenin mice ulti-
mately produce the same phenotype. A second possible
reason for the disparity could involve the use, in our study,
of an NH2-terminally deleted DN89b-catenin. This mutant
lacks sites essential for its degradation, and is therefore
commonly used to mimic Wnt-induced stabilization of
b-catenin. Deletion of the NH2-terminus, however, also
removes sites that can bind additional regulatory factors,
such as nemo-like kinase (NLK), a protein that modulates
the function and location of downstream elements of Wnt
Figure 8.  A comparison of
late involution in wt and
DN89b-catenin mammary
glands. (A) Graph of the av-
erage number of TUNEL-
positive nuclei in five random
frames taken from sections of
wt and DN89b-catenin (TG)
inguinal mammary glands
from 1, 3, 5, and 7 d after re-
moving pups as indicated.
(B) Hematoxylin and eosin–
stained sections of wt (top)
and  DN89b-catenin (bot-
tom) inguinal mammary
glands from littermates 10,
13, 16, and 21 d after remov-
ing pups. Note that in con-
trast to wt glands, which
show continued signs of dete-
rioration and reduction of
the epithelial component,
DN89b-catenin mice show
continued lobular hyper-
plasia. (C) mRNA was
extracted from mammary
glands having undergone in-
volution for 1, 13, and 21 d,
as indicated. Northern blots
were prepared and probed
with cDNAs encoding cyclin
D1, c-myc, casein, and K18 as a control to permit normalization for epithelial content of the mRNA samples. Note cyclin D1 becomes
elevated and casein mRNA persists at day 21 of involution in transgenic mice compared with their wt littermates.Imbert et al. b-Catenin in Mammary Gland 565
Figure 9.  DN89b-catenin mice develop mammary adenocarcinomas. (A) Founder mouse line 5 with single large tumor on a thoracic
mammary gland. (B) Hematoxylin and eosin–stained section of similar tumor from an F1 daughter. Tumors comprise regions of glandu-
lar hyperplasia (C and D) with central masses of disorganized, undifferentiated (U) poorly adherent cells (C, E, and F). Some showed
evidence of secretory activity (E) but most showed undifferentiated cells with a high cytoplasmic to nuclear ratio and many mitotic fig-
ures (arrowheads in D and F). (G) mRNA was extracted from mammary tumors (T) and mammary glands of wt littermates. Northern
blots were prepared and probed with cDNAs encoding cyclin D1, c-myc, and K18 as a control to permit normalization for epithelial
content of the mRNA samples. (H) Graph of tumor incidence in DN89b-catenin mice. The percentage of animals in each cohort re-
maining free of palpable tumors was plotted as a function of age for DN89b-catenin line 5 breeding females (n 5 12), line 3 breeding fe-
males (n 5 13), and line 5 virgins (n 5 13). No female wt littermates (n 5 25) or wt littermate males (n 5 20) developed tumors. To
date, among mice that are currently . 1 yr old, three line 3 virgin females (n 5 10), no line 3 males (n 5 10), and only one line 5 male
(n 5 10) have developed tumors.The Journal of Cell Biology, Volume 153, 2001 566
cascades (Ishitani et al., 1999). A third important differ-
ence involves the possibility that Wnts may operate
through additional or alternative downstream effectors
than b-catenin. While some Wnts have been shown to
stimulate G protein–coupled pathways, Wnt-1, -3, and
-10b are commonly thought to signal through b-catenin.
However, Wnt-1 expression in cultured cells also upregu-
lates plakoglobin, a close relative of b-catenin, and plako-
globin rather than b-catenin has been shown to reproduce
a Wnt-3 overexpression phenotype in mouse epidermis
(Bradley et al., 1993; Hinck et al., 1994; Charpentier et al.,
2000). In some cell types plakoglobin appears to act as an
oncogene, and in others it suppresses proliferation and tu-
morigenicity (Simcha et al., 1996; Charpentier et al., 2000;
Hakimelahi et al., 2000; Kolligs et al., 2000). It has vari-
ously been reported to augment, inhibit, or have no effect
on cytosolic levels and signaling function of b-catenin
(Merriam et al., 1997; Miller and Moon, 1997; Salomon et
al., 1997; Charpentier et al., 2000; Williams et al., 2000).
Currently, the role of plakoglobin in mammary gland is
not known, and its potential contribution to Wnt signaling
in this gland needs to be tested. 
Our data indicate that DN89b-catenin recapitulates spe-
cific elements of MMTV-Wnt-1, -3, and -10b phenotypes.
However, the endogenous Wnt pathways activated by ex-
pression of these Wnts appear to involve one additional
downstream effector or modulator. Our work is consistent
with the possibility that endogenous b-catenin functions to
trigger lobuloalveolar differentiation. Proof of this hy-
pothesis, however, requires an analysis of the effects of
blocking b-catenin signaling on the different stages of
mammary development. Overexpression of axin and dom-
inant negative forms of Tcf has been used to achieve this
effect in other systems, but has the disadvantage of poten-
tially affecting plakoglobin, which also binds to these pro-
teins (Kodama et al., 1999; Williams et al., 2000). The use
of dominant negative b-catenin appears to avoid this po-
tential problem, and we are currently exploring this ap-
proach (Montross et al., 2000).
DN89b-Catenin and Potential Downstream Targets
Our results demonstrate upregulation of E-cadherin, cy-
clin D1, c-myc, and casein in DN89b-catenin mammary
gland. An increase in E-cadherin protein levels in re-
sponse to expression of b-catenin or its relative plakoglo-
bin has been observed in other in vitro and in vivo systems
(Bradley et al., 1993; Hinck et al., 1994; Wong et al., 1998).
Indeed, the E-cadherin gene may be a transcriptional tar-
get of Wnt (Huber et al., 1996; Yanagawa et al., 1997).
However, the early DN89b-catenin phenotype resembles
that of P-cadherin null and E-cadherin dominant negative
mice, suggesting that cadherins antagonize b-catenin in
the induction of lobuloalveolar development (Radice et
al., 1997; Delmas et al., 1999).
At the present time, the most significant observation
with respect to potential downstream effectors of b-catenin
signaling involves the DN89b-catenin–induced upregula-
tion of cyclin D1 and c-myc mRNA in virgin mice. b-Cate-
nin was first demonstrated to promote expression of the
cell cycle regulators cyclin D1 and c-myc in colonic cells,
and appears to be operating in mammary gland in a similar
fashion (He et al., 1998; Tetsu and McCormick, 1999). Mice
expressing MMTV–c-myc, MMTV–cyclin D1, and MMTV-
CDC37, the chaperone for the cyclin D1 cdk4 partner, de-
velop lobuloalveolar hyperplasia and are prone to adeno-
carcinoma at z1–2 yr of age (Sinn et al., 1987; Wang et al.,
1994; Stepanova et al., 2000). There is complete congru-
ency between the early phenotype of the MMTV–DN89b-
catenin mice, and that of mice lacking cyclin D1. Analyses
of the cyclin D1 null mice show that like DN89b-catenin,
the cyclin D1 gene specifically affects lobuloalveolar devel-
opment and has no effect on ductal branching (Sicinski et
al., 1995; Fantl et al., 1999). Cyclin D12/2 mice show nor-
mal side branching but marked reduction of alveoli and a
lactation defect, a phenotype that fits exactly that predicted
for loss of a b-catenin–regulated gene.
DN89b-Catenin Induces Poorly
Differentiated Adenocarcinomas
DN89b-catenin induces hyperplasia and benign tumors in
other tissues; however, only in mammary gland does it
produce such aggressive tumors. Several molecular mech-
anisms have been invoked to explain the tumor-promoting
action of b-catenin. Endogenous cytoplasmic levels of
b-catenin oscillate with the cell cycle, and increasing b-cate-
nin expedites the G1-S phase transition (Orford et al.,
1999). This can be explained in the DN89b-catenin mam-
mary gland by the upregulation of both cyclin D1 and
c-myc. Cyclin D1–cdk4 complexes phosphorylate and func-
tionally inactivate RB, leading to release of E2F, which ac-
tivates transcription of genes necessary for the completion
of the cell cycle (Sutherland et al., 1998). Cyclin D1–cdk4
complexes also promote cyclin E/cdk2 activity by seques-
tering inhibitory p21 and p27 subunits. C-myc elevates ex-
pression of cyclin E, cdc25A, and factors that prevent for-
mation of the p27– and p21–cdk inhibitory complexes, and
lowers expression of the inhibitory p27 subunit (Suther-
land et al., 1998). Thus, the concerted actions of cyclin D1
and c-myc result in rapidly cycling cells which produce a
preneoplastic alveolar hyperplasia. Further genetic insults
to this increased pool of cells escape G1-S checkpoint con-
trol and lead to tumor progression. Overexpression of cy-
clin D1 or c-myc predisposes mice to mammary tumors,
but with much slower kinetics and penetrance than is
seen even with the low expressing DN89b-catenin line
(Stepanova et al., 2000). It is likely that the ability of
DN89b-catenin to concurrently elevate both c-myc and cy-
clin D1 accounts for the robust growth of the DN89b-cate-
nin mammary tumors. Both cyclin D1 and c-myc are
highly expressed in 40% of human breast tumors. Signifi-
cantly, more than half of these tumors show no amplifica-
tion or genetic changes in the c-myc or cyclin D1 locus
(Leder et al., 1986; Buckley and Middleton, 1987; Wang et
al., 1994). By analogy to human colon cancer, the possibil-
ity must now be investigated that mutations in tissue-spe-
cific, negative regulators of b-catenin may be involved in
such a subset of human breast cancer.
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